Shire rebuffs $46 billion takeover bid from AbbVie
June 20, 2014 at 03:29 AM EDT
U.K.-listed drug maker Shire PLC has rejected a £27.2 billion ($46.35 billion) takeover bid from U.S. rival AbbVie Inc.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.